Combination Therapy with Tenofovir Disoproxil Fumarate/Emtricitabine/Elvitegravir/Cobicistat Plus Darunavir Once Daily in Antiretroviral-Naive and Treatment-Experienced Patients: A Retrospective Review

BACKGROUND: Patients with drug-resistant HIV often require complex antiretroviral regimens. However, combining fixed-dose combination tablets such as tenofovir–disoproxil–fumarate, emtricitabine, and cobicistat-boosted elvitegravir (TDF/FTC/EVG/cobi) with darunavir (DRV) can provide a simple, once-d...

Descripción completa

Detalles Bibliográficos
Autores principales: Naccarato, Mark J., Yoong, Deborah M., Fong, Ignatius W., Gough, Kevin A., Ostrowski, Marian A., Tan, Darrell H. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748498/
https://www.ncbi.nlm.nih.gov/pubmed/29385867
http://dx.doi.org/10.1177/2325957417752260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748498/
https://www.ncbi.nlm.nih.gov/pubmed/29385867
http://dx.doi.org/10.1177/2325957417752260

Ejemplares similares